Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DPII: Discovery Partners Int'l -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (27)	10/22/2005 2:44:30 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 111

With the IRORI part of the website being taken down, I have grabbed the stuff that Nexus will be selling now... Directed Sorting Synthesis Manager Software Kan Reactors Directed Sorting Automation Combichem synthesis systems AutoSort 10k AutoWash 10k AccuCleave Stations 48, 96, 192 CleVap Accessories This search will get you to the google cache of an old IRORI catalog, as well as the website being taken down: google.com I suppose the recent further let down in the shareprice could be a reaction to having built a business, and then sold it for next to nothing. Still, getting a little cash while not having to carry the cost of these employees may be a fair trade if the business is not very profitable. Xenometrix may have gone to Nexus too. Of course DPI wrote "Discovery Partners will retain royalty free access to the transferred technologies as required to perform services or collaborations with its integrated drug discovery platform." So I am not too worried that Nexus seemingly got a lot of stuff, so long as dpi still has rights to any tech. The only thing I can thing of that may be worth looking into now, is what will be the cost of stock options and such over the next year. The biggest salaries are on the order of a half million, plus compensation of a half million. So it can add up. I don't know if everbody has worthless options on dpi stock or whether they just write new options, or whether all "compensation" is simply shares. (I never read all of the quarterly reports til my shares are underwater, ha ha)